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Interferon regulatory factor 3 (IRF3) and IRF7 modulate the transcription of type I interferon. In this issue
of Immunity, Yu and Hayward (2010) identify RAUL, the bona fide ubiquitin ligase that regulates turnover
of IRF3 and IRF7.Host protection against viral infection is
orchestrated through specific pathogen
sensing, complex signaling pathways,
and a diversity of protective responses.
The initial efforts of the infected host cell
are to limit virus replication by engaging
a broad spectrum of innate antiviral mech-
anisms while signaling the initiation of
adaptive immunity. Microbial pathogens
express defined pattern-associated mo-
lecular patterns (PAMPs) that are detected
by pattern-recognition receptors (PRRs).
Thus far, three PRR families have been
identified: the Toll-like receptors (TLRs),
the cytoplasmic retinoic acid inducible
gene (RIG-I)-like receptors (RLRs), and
thenucleotide-bindingandoligomerization
domain (NOD)-like receptors (NLRs) (Akira
et al., 2006; Takeuchi and Akira, 2010).
Engagement of a PRR will activate a
specific signaling cascade culminating in
the expression of downstream target
genes such as type I interferon (IFN),
inflammatory mediators, and host restric-
tion factors. Common to most PRR sig-
naling events is the activation of interferon
regulatory factors—IRF3 or IRF7, critical
transcriptional activators of type I IFN
gene activation. IRF3 and/or IRF7 are
phosphorylated by the noncanonical
IkB -related kinases (IKK) TANK-binding
kinase (TBK1) and IKK3 at key serine resi-dues in the C terminus of the protein after
TLR3, TLR4, or RIG-I stimulation.
The active state of these transcription
factors is tightly regulated by posttransla-
tional modifications such as phosphoryla-
tion, ubiquitination, and the addition of
interferon stimulated gene 15 (ISG15),
also known as ISGylation. Recognition
that protein ubiquitination functions as a
major regulator of signal transduction
has refocused the search for negative
regulators to the identification of E3
ligases with the potential to modulate
IRF activity and the IFN response. As
with the identification of novel kinases,
significant effort has been directed to the
discovery of E3 ligases because they
define the specificity and complexity that
is characteristic of the ubiquitination pro-
cess. In this issue, Yu and Hayward
(2010) identify RAUL as the bona fide E3
ligase that conjugates K48-dependent
Ub chains to IRF3 and IRF7, leading to
proteasome mediated degradation.
Ubiquitination, like phosphorylation, is
a reversible process controlled by a limited
numberofdeubiquitinases that specifically
cleave ubiquitin chains (Ribet andCossart,
2010). Ubiquitin (Ub) is a small peptide of
76 amino acids that is highly conserved in
all eukaryotic cells. Ub becomes conju-
gated to a target protein via formation ofan isopeptide bondbetween itsC terminus
(G76) and the 3-amino group of an
acceptor Ub lysine residue (most
commonly studied are K48 or K63)—or
directly to the amino terminus of the target
protein. Alternatively, head-to-tail linked
Ubmoieties havebeendescribed recently,
as part of the novel process of linear ubiq-
uitination (Clague and Urbe, 2010). This
highly organized posttranslational modifi-
cation requires the sequential action of
threeenzymes:E1-E2-E3.A ubiquitin-acti-
vating enzyme (E1) forms a thiol ester with
the carboxyl group of Ub, thereby acti-
vating it for nucleophilic attack. A conju-
gating enzyme (E2) transiently carries the
activated Ub molecule as a thiol ester,
and the E3 ligase transfers the activated
Ub from the E2 to the substrate.
A common strategy of many viruses is
to target key antiviral signaling proteins
for proteasomal degradation by using
either viral or host ubiquitin ligases
(Viswanathan et al., 2010). Pathogens
hijack certain posttranslational modifica-
tions to preferentially target specific host
pathways to promote their replication
and propagation and to escape from the
immune system (Ribet and Cossart,
2010) . Viral proteins that usurp the ubiqui-
tin-proteasome pathway include the
E6- associated protein (E6-AP) of humanecember 22, 2010 ª2010 Elsevier Inc. 833
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Figure 1. Ubiquitination of IRFs by RAUL-RTA-HAUSP
Upon recognition of PAMPs by their respective PRR, signal complex formation leads to IRF3 and IRF7
phosphorylation, activation, and type I IFN gene activation. Active IRF3 and IRF7 undergo proteasomal
degradation, controlled by RAUL whose ligase activity is mediated by self-ubiquitination and proteolysis.
In the context of KSHV infection, viral E3 ligase RTA will hijack RAUL and recruit deubiquitin enzyme
HAUSP. HAUSP is responsible for deubiquitinating RAUL, leading to a stable andmore active RAULwhich
in turn will more readily promote IRF3-IRF7 proteasomal degradation.
Immunity
Previewspapilloma virus, infected cell protein
0 (ICP0) of herpes simplex virus type 1,
E4orf6 and E1B55K of the adenovirus
family, viral infectivity factor (VIF) of
lentiviral viruses such as human immuno-
deficiency virus (HIV), the V protein of
rubulavirus, and replication and transcrip-
tion activator (RTA) of Kaposi’s sarcoma-
associated herpesvirus (KSHV) (Viswana-
than et al., 2010). Relevant to the present
study is the role of RTA, also known as
open reading frame 50 (Orf50), from
KSHV. RTA is a DNA-binding nuclear tran-
scription factor acting throughout the
virus replication cycle. Yu and Hayward
previously demonstrated that RTA could
bind IRF7 and induce polyubiquitination
and proteasome-mediated degradation,
via the action of the E2 ligase UbcH5a
(Yu et al., 2005). They briefly mention
that RTA also affected IRF3 stability
without detailing their findings, but
demonstrated that RTA controlled its
own polyubiquitination and stability.
In this issue, Yu and Hayward (2010)
have extended their previous studies and
provide compelling evidence that the834 Immunity 33, December 22, 2010 ª2010RTA-associated ubiquitin ligase (RAUL)
directly catalyzes K48-linked polyubiquiti-
nation of IRF3 and IRF7, tagging them for
proteasomal degradation under both
homeostatic and pathologic conditions
(Figure 1). An insightful yeast two-hybrid
screen first identified KSHV immediate-
early lytic cycle protein RTA as having
the potential binding partners of RAUL
and IRF7. Beginning with an exploration
of the target specificity of RAUL, the
authors have shown that the continuous
activity of RAUL serves to maintain
homeostatic basal amounts of IRF3 and
IRF7. RAUL was capable of binding to
IRF3 and IRF7 independently of their
phosphorylation status, making it a good
candidate for controlling basal protein
expression of IRF3 and IRF7. Both in vivo
and in vitro, RAUL directly conjugated
K48-polyubiquitin chains to IRF3 and
IRF7, thus leading to their proteasomal
degradation. In this regard, the authors
utilized various approaches to validate
their findings, from silencing RAUL to
using mutated forms of the E3 ligase in
overexpression and/or endogenousElsevier Inc.systems. A cell-free assay demonstrated
the ability of RAUL to directly ubiquitinate
IRF3 and IRF7 via the E2 ligase UbcH5a.
However, an important finding missing
from their comprehensive ubiquitination
studies was the identification of the key
lysine residues of IRF3 and IRF7 targeted
by RAUL. An unexplained aspect of their
findings is the role of RAUL in maintaining
the steady-state amounts of IRF3 and
IRF7—a curious observation considering
that IRF3 and IRF7 have notable differ-
ences in their stability profile. IRF7 has
a half-life of 30 min and contains a
PEST (proline [P], glutamic acid [E], serine
[S], and threonine [T]) domain in its
N-terminus, indicative of an unstable pro-
tein, whereas IRF3 is a stable protein with
a half-life of 24 hr and does not possess
a PEST domain. Can RAUL differentiate
between IRF3 and IRF7 sequence or
structure, thus preferentially promoting
IRF7 instability over IRF3? It remains
unclear how RAUL select its targets;
determining this would reveal whether
RAUL distinguishes between inactive
versus phosphorylated IRF3 and IRF7.
The authors proceeded to investigate
the antiviral properties of RAUL in KSHV
and Sendai virus infection models. In
both instances, the depletion of RAUL
with siRNA silencing led to an increase
in IFN-b production with a concomitant
decrease in viral replication. Reciprocal
results—decreased IFN production and
augmented viral replication—were ob-
served when RAUL was ectopically over-
expressed, thus demonstrating a negative
regulatory role for the E3 ligase RAUL in
IFN production (Yu and Hayward, 2010).
Although it has been known for more
than a decade that IRF3 is targeted for
proteasomal degradation after virus infec-
tion (Lin et al., 1998), theE3ubiquitin ligase
and related signals responsible for its
degradation have remained elusive.
Previous studies have identified several
putative cellular E3 ligases involved in
the ubiquitination of IRF3, such as Ro52,
Cull-1, RBCK1, and SOCS1 (Higgs and
Jefferies, 2008), as well as the peptidyl-
prolyl isomerase Pin1 (Saitoh et al.,
2006). In the context of IRF7, RIP-1,
TRAF6, RTA, and LMP1 were identified
as E3 ligases, of cellular and viral origin,
capable of regulating type I IFN by orches-
trating IRF7 ubiquitination (Higgs and Jeff-
eries, 2008). An important consideration in
the present study is the fact that the
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Previewsauthors also investigated the previously
identified E3 ligases RBCK1 and Ro52
and their involvement in the IRF3 ubiquiti-
nation. Their results demonstrated that
these E3 ligases play a role in negative
regulation of IRF3, but RAUL is the prin-
cipal E3 ligase involved in degradation of
IRF3 and IRF7 (Yu and Hayward, 2010).
The authors broadened their study of
RAUL by revealing a role for viral RTA in
the evasion of the host immune response.
It is this link with KHSV pathogenesis that
further distinguishes this study (Yu and
Hayward, 2010). They demonstrated
that RTA can hijack cellular RAUL and
modulate the stability of RAUL by recruit-
ing the deubiquitinating enzyme HAUSP.
Silencing HAUSP led to an increase in
RAUL stability by preventing self-ubiquiti-
nation and proteolysis. By taking control
of HAUSP, RTA enhanced RAUL activity,
leading to greater IRF3 and IRF7 protea-
somal degradation. Considering that RTA
itself possesses E3 ligase activity capable
of targeting IRF3 and IRF7 for degradation(Yu et al., 2005), the question arises as to
why KSHV goes through the trouble of
hijacking RAUL and recruiting HAUSP,
instead of simply using RTA to promote
IRF3 and IRF7 degradation? The question
may be more complex, considering that
IRF3 is essential for induction of host
restriction factors within the context of
an ongoing IFN response. Redundantly
targeting both IRF3 and IRF7 for degrada-
tion may be a safeguard in the context of
virus replication and immune evasion.
These anti-IRF countermeasures may
also serve as a switch between cycles of
lytic and latent KSHV infection. Perhaps
the RTA-HAUSP-RAUL complex also
assists KSHV to downregulate its viral
IRF-like proteins that are induced during
viral reactivation and thus favors a shift
toward latent infection. Beyond the scope
of the authors’ contributions to the under-
standing of RAUL biology and IRF degra-
dation, these findings are likely to provide
insights into the pathogenesis of KSHV-
associated disease.Immunity 33, DREFERENCES
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In this issue of Immunity, Kerdiles et al. (2010) report that Foxo transcription factors are essential for the
development and function of Foxp3-expressing regulatory T (Treg) cells via controlling the expression of
genes associated with Treg cell function.Foxo transcription factors belong to the
Forkhead box family of transcription
factors characterized by a conserved
winged helix DNA binding domain. In
mammals, the Foxo subfamily is com-
prised of four members, Foxo1, Foxo3,
Foxo4, and Foxo6. Foxo1 and Foxo3 are
the main isoforms expressed in the
immune system. They are important
regulators of cell cycle progression, apo-
ptosis, glucose metabolism, and stress
resistance via integrating information of
the presence of nutrients, growth factors,
and stress signals. Recent studies haveshown that Foxo transcription factors are
also associated with lymphocyte func-
tions such as gene recombination,
homing, and cytokine receptor expres-
sion. Although Foxo transcription factors
appear to play important roles in a variety
of biological processes, the functions of
Foxo1 and Foxo3 in T cells still remain
obscure. In this issue of Immunity, Ker-
diles et al. (2010) investigate autoimmunity
resulting from T cell-specific deletion of
Foxo1 and additional deletion of Foxo3.
They conclude that Foxo transcription
factors are essential for specifying theprogram of T cell differentiation especially
into regulatory T (Treg) cells expressing
the transcription factor Foxp3 (Figure 1).
Foxo transcription factors can act as
either transcriptional activators or repres-
sors by forming different molecular com-
plexes with different transcriptional
modulators including b-catenin, STAT3,
Runx3, Smad3, or Smad4. In addition,
their function is tightly regulated by the
upstream phosphoinositide 3-kinase
(PI3K) and Akt pathway, which phosphor-
ylates Foxo molecules and facilitates their
nuclear export into the cytoplasm. Afterecember 22, 2010 ª2010 Elsevier Inc. 835
